TORONTO, ON / ACCESS Newswire / November 20, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the third quarter ended September 30, 2025, with quarterly revenue growth of $546,714 to$4,616,066 and quarterly EBITDA growth of $441,224 (to$887,671). ...